Cargando…
Adjuvanted Immunotherapy Approaches for Peanut Allergy
Food allergies are a growing public health concern with an estimated 8% of US children affected. Peanut allergies are also on the rise and often do not spontaneously resolve, leaving individuals at-risk for potentially life-threatening anaphylaxis throughout their lifetime. Currently, two forms of p...
Autores principales: | Johnson-Weaver, Brandi T., Staats, Herman F., Burks, A. Wesley, Kulis, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167456/ https://www.ncbi.nlm.nih.gov/pubmed/30319619 http://dx.doi.org/10.3389/fimmu.2018.02156 |
Ejemplares similares
-
Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy
por: Suber, Jada, et al.
Publicado: (2022) -
Current Insights into Immunotherapy Approaches for Food Allergy
por: Macdougall, Jessica D, et al.
Publicado: (2021) -
Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy
por: Wright, Benjamin L., et al.
Publicado: (2018) -
Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible Mice
por: Smeekens, Johanna M., et al.
Publicado: (2021) -
Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)